|
CCDC88C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.558000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.198000E-03 |
| Normal-vs-Stage2 |
8.658200E-01 |
| Normal-vs-Stage3 |
5.001500E-02 |
| Normal-vs-Stage4 |
4.792300E-02 |
| Stage1-vs-Stage2 |
4.720400E-03 |
| Stage1-vs-Stage3 |
3.041000E-01 |
| Stage1-vs-Stage4 |
7.813600E-01 |
| Stage2-vs-Stage3 |
6.560300E-02 |
| Stage2-vs-Stage4 |
4.837700E-02 |
| Stage3-vs-Stage4 |
6.677600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.924000E-03 |
| Normal-vs-AfricanAmerican |
7.070000E-02 |
| Normal-vs-Asian |
5.218600E-03 |
| Caucasian-vs-AfricanAmerican |
7.025400E-01 |
| Caucasian-vs-Asian |
1.515780E-01 |
| AfricanAmerican-vs-Asian |
5.934800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.987920E-02 |
| Normal-vs-Female |
8.897000E-03 |
| Male-vs-Female |
7.823600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.861900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.553700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.219200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.476450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.326000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.924600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.748400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.462300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.210200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.022200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.022000E-01 |
| Classical-VS-Follicular |
5.60610002864337E-10 |
| Classical-VS-Other |
3.476000E-01 |
| Classical-VS-Normal |
3.353100E-04 |
| Tall-VS-Follicular |
8.831800E-04 |
| Tall-VS-Other |
4.361200E-01 |
| Tall-VS-Normal |
3.961500E-02 |
| Follicular-VS-Other |
2.782800E-01 |
| Follicular-VS-Normal |
4.531000E-01 |
| Other-VS-Normal |
5.937200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.725440E-01 |
| Normal-vs-N1 |
4.215700E-02 |
| N0-vs-N1 |
1.865400E-01 |
|
|
